Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials.

about

Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials.

Item

http://www.wikidata.org/entity/Q55081727

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Comparison of maintenance effe ...... randomized controlled trials.

@en

Comparison of maintenance effe ...... randomized controlled trials.

@nl

type

Item

label

Comparison of maintenance effe ...... randomized controlled trials.

@en

Comparison of maintenance effe ...... randomized controlled trials.

@nl

prefLabel

Comparison of maintenance effe ...... randomized controlled trials.

@en

Comparison of maintenance effe ...... randomized controlled trials.

@nl

P1476

Comparison of maintenance effe ...... randomized controlled trials.

@en

P2093

Feng-Xiang Qi

http://www.w3.org/2001/XMLSchema#string

Tao Han

http://www.w3.org/2001/XMLSchema#string

Ying Zhang

http://www.w3.org/2001/XMLSchema#string

Yong Jiang

http://www.w3.org/2001/XMLSchema#string

Zhi-Guang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Probiotics for maintenance of remission in ulcerative colitis

Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Probiotic Mix VSL#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?

Antibiotics and probiotics in treatment of inflammatory bowel disease.

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease

P304

34-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CDTM.2016.07.002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29063023

http://www.w3.org/2001/XMLSchema#string

P921

probiotics

P932

5643593

http://www.w3.org/2001/XMLSchema#string